These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29475141)

  • 1. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
    Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K
    Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters.
    Li K; Lai H
    Biomed Pharmacother; 2017 Dec; 96():371-377. PubMed ID: 29028589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
    Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K
    Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer.
    Li K; Liu W; Zhao Q; Wu C; Fan C; Lai H; Li S
    Phytother Res; 2019 Jun; 33(6):1658-1669. PubMed ID: 30945389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin.
    Sheu MT; Jhan HJ; Hsieh CM; Wang CJ; Ho HO
    Integr Cancer Ther; 2015 Mar; 14(2):184-95. PubMed ID: 25542609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of quercetin on doxorubicin cytotoxicity in human breast cancer cells.
    Li SZ; Li K; Zhang JH; Dong Z
    Anticancer Agents Med Chem; 2013 Feb; 13(2):352-5. PubMed ID: 22721393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells.
    Staedler D; Idrizi E; Kenzaoui BH; Juillerat-Jeanneret L
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1161-72. PubMed ID: 21400027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin-Stabilized Polymeric Micelles (L
    Chang CE; Hsieh CM; Huang SC; Su CY; Sheu MT; Ho HO
    Sci Rep; 2018 Dec; 8(1):17640. PubMed ID: 30518853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway.
    Li SZ; Qiao SF; Zhang JH; Li K
    Anticancer Agents Med Chem; 2015; 15(9):1185-9. PubMed ID: 25612678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
    Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
    Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J; Zhang W; Wu J; Zhu Y
    Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells.
    Chaisit T; Siripong P; Jianmongkol S
    Eur J Pharmacol; 2017 Jan; 795():50-57. PubMed ID: 27916559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
    Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
    Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
    Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
    Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
    Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.